About FDA
-
Extramural Research Funding by State and Recipient for FY 2003
<< Return to FY 2005 Budget Proposal
Department of Health and Human Services
Food and Drug Administration
Fiscal Year 2005
FOOD AND DRUG ADMINISTRATION
Extramural Grant Research — FY 2003
| STATE | RECIPIENT | PROJECT TITLE | AMOUNT |
|---|---|---|---|
| AL | University of Alabama | Assessment of Chronic GBS Improvement with use of 4-AP | $195,408 |
| AR | Biokinetic Controls, Inc. | Ensuring Food Safety for Ready-to-Eat Deli Products | $100,000 |
| AR | Biokinetic Controls, Inc. | Ensuring Food Safety for Ready-to-Eat Deli Products | $100,000 |
| AZ | Arizona Department of Agriculture | Arizona Food Safety Task Force Meetings | $2,632 |
| AZ | University of Arizona | Role of Irrigation Methods on Microbial Food Safety | $177,514 |
| AZ | University of Arizona | Clinical Trial of Scorpion Antivenom (US and Mexico) | $285,400 |
| CA | Children's Hospital Medical Center | Arginine Therapy for Acute Chest Syndrome in Sickle Cell | $308,143 |
| CA | Chromadex, Inc. | Rapid Screening of Foods for Toxins by TLC-Bioluminescence | $512,095 |
| CA | County of Orange Health Care Agency | Traditional Foods Project - A collaborative approach to ensuring safe food handling in the Vietnamese community | $44,920 |
| CA | FeRx, Inc. | MTC-DOX in Subjects with HCC | $300,000 |
| CA | Neurochem, Inc. | Safety & Efficacy of NC-503 in Secondary Amyloidosis | $297,874 |
| CA | University of California | Immune Monitor for COG Trial of Anti-GD2 in Neuroblastoma | $262,369 |
| CA | University of Southern California | Novel Adjuvants for Peptide-Based Melanoma Vaccines | $380,155 |
| DC | Children's Research Institute | Phase I Study of Pirfenidone in Children with PNS in NF1 | $185,816 |
| DC | National Academy of Sciences | Nutrient Requirements of Domestic Animals and Critical Roles of Animal Nutrition | $20,000 |
| DC | Naval Research Laboratory | Multi-Analyte Array Sensor for Food-Borne Contaminants | $153,000 |
| DC | Naval Research Laboratory | Rapid Food Screening | $570,600 |
| FL | University of Florida | Prevention of Dichloroacetate Toxicity | $426,657 |
| GA | Inhibitex, Inc. | Veronate for Staph Prophylaxis in Neonates | $300,000 |
| GA | University of Georgia Research Foundation | Development of Waveguide Immunoassay for Yersinia Pestis | $600,000 |
| IA | Iowa State University | Veterinary Antimicrobial Decision Support System (VADS) | $249,108 |
| IA | University of Iowa Hospitals and Clinics | OK-432 Sclerotherapy - A Multicenter Trial | $265,800 |
| IL | Illinois Institute of Technology | National Center for Food Safety and Technology | $3,000,000 |
| IL | Institute of Food Technologists | Risk-Ranking Framework to Evaluate Potential High Threat Microorganisms | $180,462 |
| IN | Indiana Univeristy | Indiana University Clinical Pharmacology | $200,000 |
| KY | Phoenix Pharmacologics, Inc. | Phase I Testing of Unicase-PEG 20 | $73,346 |
| KY | Phoenix Pharmacologics, Inc. | Phase II Testing of ADI-PEG 20 in Hepatocellular Carcinoma | $300,000 |
| MA | Children's Hospital | Clotrimazole Enemas for Pouchitis in Childrens and Adults | $212,265 |
| MA | Holles Laboratories, Inc. | Topical DEHYDREX in Treating Recurrent Corneal Erosion | $250,000 |
| MA | Massachusetts General Hospital | TheraDerm Administration in Women with Hypopituitarism | $471,088 |
| MA | Trustees of Boston University | Erythropoiesis and Pulse Arginine Buytrate in sickle Cell Disease | $453,578 |
| MD | EntreMed, Inc. | Recombinant Human Endostatin in Patient with Neuroendocrine | $300,000 |
| MD | Johns Hopkins University | Phase II Trial of Moxifloxacin for TB | $408,201 |
| MD | Spectral Dimensions | High-throughput Inspection of Drugs by NIR Spectroscopy | $99,500 |
| MD | University of Maryland, College Park | Cooperative Agreement to Support the Joint Institute for Food Safety and Applied Nutrition | $2,280,000 |
| MI | Michigan State University | Transfer Coefficients for Listeria Cross-Contamination | $150,835 |
| MI | University of Michigan | MIBG plus Intensive Chemotherapy for Neroblastoma | $889 |
| MI | University of Michigan | Safety and Efficacy of Recombinant Human Keratinocyte Growth Factor (rHUKGF) in Unrelated/Related Transplants | $222,644 |
| MI | University of Michigan | Treatment of Graft-vs.-Host Disease Using Enbrel | $228,016 |
| MI | University of Michigan | Phase III Study of tetrathiomolybdate Does Regimen in Initial Neurological Wilson's Disease | $255,498 |
| MI | University of Michigan | Phase III Trial of Tgetrthiomolybdate I Initial Hepatic Wilson's Disease | $257,257 |
| MN | Mayo Clinic Rochester | Giant Cell Myocarditis Treatment Trial Pilot Study | $207,931 |
| MO | Children's Mercy Hospital and Clinics | Hydroxychloroquine for Grant-vs.-Host Disease | $8,858 |
| MS | University of Mississippi | Botnical Dietary Supplements: Science-Base for Authentication | $832,557 |
| MS | University of Mississippi | Botnical Dietary Supplements: Science-Base for Authentication | $564,156 |
| MX | Fundacion Mexicana Para la Salud | Susceptibility of Foodborne Pathogens from Humans, Food and Animals | $3,000 |
| MX | Fundacion Mexicana para la Salud | Susceptibility of Foodborne Pathogens from Humans, Food and Animals | $549,201 |
| NC | Duke University Medical Center | Trial of Mycophenolate Mofetil in Myasthenia Gravis | $413,559 |
| NC | North Carolina State University | Degradation of Prions: Yeast Prion as Surrogate Protein | $89,211 |
| ND | Dakota Technologies, Inc. | Fecal Contimination Sensor using Fluorescent Liposomes | $95,516 |
| NJ | University of Medicine and Dentistry of New Jersey | Pilot Study of Aminiopterin for Patients with Acute Lymphoblastic Leukemia | $245,475 |
| NM | New Mexico State University | Improving Safety of Fresh Fruits and Vegetables - Design Contest | $101,308 |
| NY | Cornell University | Rapid Immunoassay Silver Amplification Test | $546,470 |
| NY | Cornell University | Development of PCR Device for Pathogen Detection | $599,954 |
| NY | Esensors, Inc. | Patient Dose Tracking System for Fluoroscopic Procedures | $339,110 |
| NY | Mount Sinai School of Medicine | Fluoxetine vs. Placebo in Adult Autistic Disorder | $339,568 |
| NY | Mt. Sinai School of Medicine | Renegal in the Treatment of PXE | $381,404 |
| NY | New York University School of Medicine | Interaperitoneal Floxuridine in Gastric Carcinoma | $207,315 |
| NY | Sloan-Kettering Institute for Cancer Res. | Risk-adapted Therapy for AL Amyloidosis | $202,142 |
| NY | Trustees of Columbia University | Treatment of Male Osteoporosis with Parathyroid Hormone | $317,449 |
| OH | Case Western Reserve University | Restoration of Hand-Arm Function with Neuroprosthese | $227,554 |
| OH | Children's Hospital Med. Center | Triptorelin for Ovary Protection in Childhood Lupus | $447,000 |
| OH | Children's Hospital Medical Center | Anti-IL-5 for Hypereosinophilia | $215,789 |
| OH | Cincinnati Children's Hospital Medical Center | Trial of Alendronate Disodium in Pediatric Gaucher Disease | $375,491 |
| OH | University of Cincinnati | Cultured Skin Substitutes for Closure of Burn Wounds | $370,845 |
| PA | Agentase LLC | Biocatalytic Polymer Indicators of Fish Freshness | $97,924 |
| PA | Pennsylvania State University | Treatment of Advanced Pancreatic Cancer with Opioid Growth Factor | $350,785 |
| Peru | Universidad Peruana Cayetano Heredia | Comparison of 2 Lengths of Albendazole Therapy for Subarachnoid | $299,593 |
| SC | Interstate Shellfish Sanitation Conference | Shellfish Safety Assistance Project | $325,000 |
| SC | Medical University of South Carolina | Phase II Study of Alendronate in Juvenile Osteoporosis | $325,865 |
| TN | Tennessee State University | Protein Markers for Verifying Inactivation of TSE Agents | $159,518 |
| TN | Vanderbilt University Medical Center | Inhibition of NF-kB Signaling in Melanoma Therapy | $226,500 |
| TX | University of Texas MD Anderson Cancer Center | Clofarabine in Chronic Lymphocytic Leukemia | $220,968 |
| TX | University of Texas MD Anderson Cancer Center | Phase II Clinical/Pharmacodynamic Investigation of Clofarabine | $2,231 |
| TX | University of Texas MD Anderson Cancer Center | Clinical and Pharmacodynamic Investigation of Clofarabine in Leukemias | $334,688 |
| TX | University of Texas Medical Branch | Database Approach for Predictio of Food Allergenicity | $246,281 |
| WA | Children's Hospital and Regional Medical Center | Triostat in Children During CPB | $388,757 |
| WA | University of Washington | Treatment of Tyrosinemia-1 with NTBC | $219,829 |
| WA | University of Washington | Optical Biosensor Technology for Food Safety | $199,404 |
| WI | University of Wisconsin | Heat Treatment of Bacterial Spores in Dairy Products | $58,538 |
| WI | University of Wisconsin | Heat Treatment of Bacterial Spores in Dairy Products | $138,985 |
| Grand Total | $26,356,799 | ||
<< Return to FY 2005 Budget Proposal
-
-
